MIKYONG SUH: Open Payments
NPI 1851721377 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 45 payments from 9 companies in 2025. Trend: 2023 $958 · 2024 $934 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $159 |
| Teva Pharmaceuticals USA, Inc. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 6 | $106 |
| Vanda Pharmaceuticals Inc. | 5 | $96 |
| Janssen Pharmaceuticals, Inc | 4 | $88 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
| Lundbeck LLC | 2 | $50 |
| Alkermes, Inc. | 2 | $37 |
Products named: VRAYLAR, REXULTI, UZEDY, COBENFY, FANAPT, INVEGA SUSTENNA, INGREZZA, ABILIFY MAINTENA.
Industry payments across IL — which companies pay providers there.
